SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
33.00    0.00 (0.00%)
Bid:
32.00
Ask:
34.00
Spread: 2.00 (6.25%)
Market Cap: £57.87m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

Further Goliath Technical Milestone Achieved

3 Oct 2024 07:00

RNS Number : 7118G
Ilika plc
03 October 2024
 

Ilika plc

("Ilika", the "Group", or the "Company")

 

Further Goliath Technical Milestone Achieved

 

D5 testing complete; safety characteristics confirmed to be superior to lithium-ion equivalents

 

Ilika (AIM: IKA), an independent global expert in solid-state battery technology, announces it has completed testing of its Goliath D5 prototypes, thereby further confirming the safety characteristics of Ilika's batteries.

 

The testing reconfirmed the benefits of Goliath relative to lithium-ion equivalent across a number of key variables - reinforcing the fact that Ilika's cells have the potential to provide electric vehicles (EV) with lighter, safer, cheaper batteries with longer ranges and faster charging capabilities.

 

Further to the RNS Reach dated 05 September 2024 https://tinyurl.com/xeydwhkp, the completion of the testing of the D5 prototypes is a key milestone, with the Company focused on delivering on its minimum viable product (MVP) roadmap, which will underpin licensing opportunities.

 

The D5 prototype is designed to build on the characteristics of the D4 data point achieved in 2023. This was achieved by optimising the cell architecture to increase Goliath's unique safety value proposition without compromising cell energy density. The key findings from the testing programme provide further validation along the development curve to D8 and MVP samples during calendar year 2025:

 

· Exceptional results from the nail penetration test carried out by University College London as part of the Faraday Institution funded Safebatt Industrial Sprint programme.

The results classify puncturing the D5 prototypes as a EUCAR 3 hazard event, with no leakage, no venting, no fire or flame, no rupture and no explosion. In contrast, puncturing the benchmark lithium-ion battery resulted in a higher EUCAR 6 event, i.e. a rupture accompanied by flying parts of the active mass, fire and flame.

· Components confirmed to be non-flammable by DEKRA, the world's largest independent, non-listed expert organisation in testing, certification and inspection.

· Temperatures during failure approximately 300°C lower than comparable Li-ion cells shown in Accelerated Rate Calorimetry testing carried out as part the Industrial Sprint, by the University of Oxford.

· Improved capacity at higher discharge rates.

D5 prototypes can be discharged at twice the rate of P1 prototypes without impacting their capacity.

 

Improved safety performance of Goliath batteries relative to conventional lithium ion means that EV designers can reduce the mechanical protection and reinforcement that would otherwise be required to protect the battery pack. In turn, this enables lighter and less expensive EV designs that have a longer range for the same amount of energy. The D5 data point makes this improved safety performance clear.

 

Ilika's CEO, Graeme Purdy, stated: "While our test programme will continue throughout our journey to a minimum viable product, we're delighted with this positive outcome. The validity of the results is enhanced by the independent execution of the tests carried out by University College London and the University of Oxford under the Faraday Institution's Safebatt Industrial Sprint programme and by DEKRA.

 

"Meeting our D5 milestone pushes our technology further along the curve towards D6, which is a data point for larger area 10Ah batteries, the results of which we expect to announce in November 2024."

 

The Faraday Institution's CEO, Professor Martin Freer, stated:

"We congratulate Ilika on achieving this milestone on their roadmap to a minimum viable product. The collaboration is a terrific example of the transfer of knowhow from the Faraday Institution community - in this case at UCL and the University of Oxford on the science of battery safety - to deliver impact for a UK battery SME via the Industry Sprint programme."

 

 

 

For more information contact:

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Jason Stewart, Chief Financial Officer

Panmure Liberum Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber, John More,

Nikhil Varghese, Josh Borlant

Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Mark Whitmore, Detlir Elezi,

Natasha Ninkov

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Nick Rome, Joe Walker

Mob: 07748 325 236

 

 

About Ilika plc - https://www.ilika.com

Ilika specialises in the developing and commercialisation of solid-state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.

 

The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

 

About SafeBatt: https://www.safebatt.ac.uk

The Faraday Institution's SafeBatt project is a collaboration, led by the University of Oxford, of seven universities (Oxford, University College London, King's College London, Newcastle, Sheffield, Warwick and Cambridge) as well as industrial partners, each bringing unique capabilities to the investigation of the science of battery safety.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFSUFIEELSELS
Date   Source Headline
21st May 20267:00 amRNSIlika Trading Update and Notice of Results
10th Apr 20264:01 pmRNSCollaboration with Brompton Bicycles
18th Mar 20267:00 amRNSPositive Feedback on Safety of Goliath Cells
10th Mar 20267:00 amRNSFirst Commercial Delivery to Cirtec Medical
24th Feb 202610:21 amRNSAward of Share Options
19th Feb 20267:00 amRNS-RIlika at Yellowstone Investor Evening: Replacement
22nd Jan 20267:00 amRNSHalf-year Financial Report
21st Jan 20267:00 amRNSIlika Secures Stereax Electrode Order from Cirtec
18th Dec 20257:00 amRNSInitial Stereax M300 Shipments
11th Dec 20257:00 amRNSIlika Ships 10Ah Goliath Battery Prototypes
20th Nov 20257:00 amRNSTrading Update & Notice of Half-Year Results
21st Oct 20257:00 amRNSCommissioning Complete for Goliath Pilot Line
1st Oct 202512:00 pmRNSExercise of Options and Total Voting Rights
23rd Sep 20253:43 pmRNSResult of AGM & Award of Executive Share Options
22nd Sep 20257:00 amRNSStart of Primed Solid-State Battery Programme
28th Aug 20257:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20257:00 amRNSStereax Battery Milestone at Cirtec Medical
17th Jul 20258:56 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSFinal Results
15th Jul 20257:00 amRNSAward of Government Grant Funding
11th Jun 20252:09 pmRNSNotice of Results
4th Jun 20252:14 pmRNSHolding(s) in Company
3rd Jun 20251:57 pmRNSHolding(s) in Company
28th May 20256:00 pmRNSResult of Oversubscribed Retail Offer
22nd May 20252:16 pmRNSRetail Offer for up to £0.5 million
22nd May 20251:53 pmRNSResult of Placing & Director Subscription
21st May 20255:14 pmRNSProposed Capital Raise
7th May 202510:03 amRNS-RIlika announces 2025 Investor Day
1st May 20257:00 amRNSGoliath P1 Cells Validated by Customer Testing
15th Apr 20257:00 amRNSGoliath Battery Achieves Scale-up Milestone
6th Mar 20257:00 amRNSGoliath Development Progress
27th Feb 20257:00 amRNSAward & Exercise of Share Options
6th Feb 20253:49 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSGoliath Scale-up Progress
21st Jan 20257:00 amRNSHalf-year Results
9th Jan 20257:00 amRNSStereax Equipment Commissioning Completed
19th Dec 20247:00 amRNSAppointment of Nominated Adviser and Sole Broker
22nd Nov 20242:18 pmRNSAIM Rule 17 Schedule 2(g) Update
20th Nov 20247:00 amRNSGoliath D6 milestone reached
15th Nov 20247:00 amRNSTrading Update & Notice of Half-Year Results
10th Oct 20241:49 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSFurther Goliath Technical Milestone Achieved
29th Aug 20247:00 amRNSPosting of Annual Report and Notice of AGM
11th Jul 20247:00 amRNSFinal Results
2nd Jul 20247:00 amRNSKey Technology Validation Milestone
1st Jul 20247:00 amRNSNominated Adviser and Joint Broker
31st May 20242:29 pmRNSHolding(s) in Company
29th May 202411:52 amRNSResults of General Meeting Open Offer and TVR
22nd May 20247:00 amRNSKey Goliath Technology Validation Milestone
16th May 20247:00 amRNSTrading Update, Notice of Results & Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.